ENLEOFEN BIO
Who is ENLEOFEN BIO?
Enleofen Bio is a biotech company focused on developing first-in-class antibody therapeutics for treating fibrotic human diseases. Founded as a spin-off from National Heart Centre Singapore, SingHealth, and Duke-NUS Medical School, we have secured Series A funding to translate research findings into...See more
Industry & Specialities
Others
Countries of Operation
Singapore
Headquarters:
Singapore
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2017 (9 years)
Address:
160 ROBINSON ROAD; SBF CENTER, #23-02; SINGAPORE, SINGAPORE 068914, SG
Employees by Department
- Operations (1)
- The Rest (1)
- Total (2)
Key Decision Makers
Susanne Weber
Operations Manager
Justin Lau
Non Executive Director
Insight
Signals
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
0employees
Senior
0employees
Non-managers
0employees
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has ENLEOFEN BIO been operating for?
- What is the funding status of ENLEOFEN BIO?
- Where is ENLEOFEN BIO's headquarter?
- What ENLEOFEN BIO's spending power?
- Does ENLEOFEN BIO have a presence in the domain it operates in?